Advanced Ultrasonography Services at Pet Point Veterinary Clinic Ultrasonography at Pet Point Veterinary Clinic combines cutting-edge technology with compassionate care, offering a comprehensive diagnostic approach for your beloved pets. Our skilled veterinary team utilizes state-of-the-art ultrasound equipment to provide detailed and non-invasive imaging of internal organs, aiding in the swift and accurate diagnosis of various medical conditions. At Pet Point, we understand the importance of early detection and precise diagnostics in ensuring the well-being of your furry companions. Our experienced veterinarians use ultrasonography to evaluate the abdominal and thoracic regions, facilitating the identification of abnormalities such as tumors, organ malformations, and fluid accumulation. The clinic's commitment to excellence extends beyond technology; our staff is dedicated to creating a stress-free environment for both pets and their owners. We prioritize open communication, ensuring that you are well-informed and comfortable throughout the ultrasonography process. https://www.petpoint.ae/services/ultrasonography/ #Pet_Point_Veterinary_Clinic #in_house_laboratory_for_pet #laboratory_for_pet #laboratory_for_animal #veterinary_laboratory_in_dubai #animal_laboratory #animal_test #animal_test_price #animal_test #veterinary #veterinary_clinic #vet_clinic_dubai #veterinary_clinic_dubai #veterinary_clinic_near_me

Organ on a Chip market Professional Survey Report by 2035 With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry. Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses. By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:  Type of Product  Organ(s) based  Disease(s) based  Type of Application Area  Drug Discovery and Toxicity Testing  Cancer Research  Tissue Engineering and Regenerative Medicine  Stem Cell Research  Purpose  Research Use  Therapy Development  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World (RoW) The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:  BEOnChip  Dynamic42  Emulate  MIMETAS  SynVivo  TissUse  uFluidix Table of Contents 1. Preface 2. Executive Summary 3. Introduction 1. Organ-on-Chip: Market Landscape 2. Organ-on-Chip Developers: Company Profiles 3. Patent Analysis 4. Brand Positioning Matrix 5. Academic Grants Analysis 6. Partnerships and Collaborations 7. Funding and Investment Analysis 8. Case Study: Scaffold-Free 3D Cell Culture Systems 9. Organ-on-Chip: Market Forecast and Opportunity Analysis 10. Conclusion 14. Executive Insights 15. APPENDIX 1: TABULATED DATA 16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html You may also be interested in the following titles: Blockchain Technology in Healthcare Market Long-Acting Drug Delivery Technologies and Services Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #organonchipproductsandtechnologies #organonachipmodels #OrganonaChipmarket #OrganonaChipmarketsize

The organ-on-chip market is anticipated to grow at a CAGR of 21.3% till 2035 In order to overcome the limitations and challenges related to animal testing, researchers and industry stakeholders are gradually adopting organ-on-chip products and technologies, which offer multiple benefits over conventional systems. Roots Analysis has announced the addition of “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” report to its list of offerings. With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry. Several players have opted to modernize their conventional testing models with organ-on a chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/organ-on-a-chip-market/request-sample.html Key Market Insights Around 145 organ-on-chip products and technologies are offered by 45+ players Nearly 67% of the aforementioned products and technologies are commercialized; of these, 93% products and technologies are intended for drug discovery and toxicity testing related applications, followed by cancer research (44%), stem cell research (32%) and tissue engineering and regenerative medicine (21%). 420+ patents related to organ on a chip products and technologies were filed / granted, since 2017 Based on the intellectual property distribution across the world, R&D activity related to organ on a chip technology and product is largely concentrated in China (over 30%), followed by the US (24%). The majority of the patents in this domain were filed by non-industry players (55%). More than 345 grants have been awarded to support the ongoing research for organ-on-chip models Grants worth USD 167 million have been awarded to various companies / organizations working in this domain till July 2022. Further, the number of grants awarded to stakeholders in this domain (in the US) has continuously increased between 2019 and 2021. Around 20% of the grants were funded by the National Center for Advancing Translational Sciences. Partnership activity in this domain has increased at a significant pace, between 2017 and 2022 The maximum number of partnerships were established in 2020 and 2021 (21, each), indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that the majority of the deals were technology / product utilization agreements, representing around 30% of the total number of partnerships signed in the given time period. Amount worth over USD 680 million was invested by both private and public investors in this domain, since 2017 Of the total amount invested, around USD 385 million was raised through grants / awards, representing around 55% of the overall funding activity in this domain. Further, 13 instances of venture capital financing were also reported, wherein players collectively raised more than USD 215 million. North America and Europe are anticipated to capture over 75% of the market share by 2035 The market in Asia-Pacific and Rest of the World are anticipated to grow at a relatively faster rate to occupy overall 24% of the total market. In addition, it is worth noting that organ(s) based models are likely to capture more than 70% of the market. For additional details, please visit https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. 3D Cell Culture Market (4th Edition): Industry Trends and Global Forecast, 2022-2035 2. Artificial Intelligence in Oncology Market: Industry Trends and Global Forecast, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com

The organ-on-chip market is anticipated to grow at a CAGR of 21.3% till 2035 In order to overcome the limitations and challenges related to animal testing, researchers and industry stakeholders are gradually adopting organ-on-chip products and technologies, which offer multiple benefits over conventional systems. Roots Analysis has announced the addition of “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” report to its list of offerings. With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry. Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/organ-on-a-chip-market/request-sample.html Key Market Insights Around 145 organ-on-chip products and technologies are offered by 45+ players Nearly 67% of the aforementioned products and technologies are commercialized; of these, 93% products and technologies are intended for drug discovery and toxicity testing related applications, followed by cancer research (44%), stem cell research (32%) and tissue engineering and regenerative medicine (21%). 420+ patents related to organ on chip products and technologies were filed / granted, since 2017 Based on the intellectual property distribution across the world, R&D activity related to organ on a chip technology and product is largely concentrated in China (over 30%), followed by the US (24%). The majority of the patents in this domain were filed by non-industry players (55%). More than 345 grants have been awarded to support the ongoing research for organ-on-chip models Grants worth USD 167 million have been awarded to various companies / organizations working in this domain till July 2022. Further, the number of grants awarded to stakeholders in this domain (in the US) has continuously increased between 2019 and 2021. Around 20% of the grants were funded by the National Center for Advancing Translational Sciences. Partnership activity in this domain has increased at a significant pace, between 2017 and 2022 The maximum number of partnerships were established in 2020 and 2021 (21, each), indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that the majority of the deals were technology / product utilization agreements, representing around 30% of the total number of partnerships signed in the given time period. Amount worth over USD 680 million was invested by both private and public investors in this domain, since 2017 Of the total amount invested, around USD 385 million was raised through grants / awards, representing around 55% of the overall funding activity in this domain. Further, 13 instances of venture capital financing were also reported, wherein players collectively raised more than USD 215 million. North America and Europe are anticipated to capture over 75% of the market share by 2035 The market in Asia-Pacific and Rest of the World are anticipated to grow at a relatively faster rate to occupy overall 24% of the total market. In addition, it is worth noting that organ(s) based models are likely to capture more than 70% of the market. For additional details, please visit https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. 3D Cell Culture Market (4th Edition): Industry Trends and Global Forecast, 2022-2035 2. Artificial Intelligence in Oncology Market: Industry Trends and Global Forecast, 2022-2035 Contact: Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com